Aster Capital Management’s Astrana Health ASTH Stock Holding History

Aster Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-259	Closed	-$6.43K	–	1402
2025 Q4	$6.43K	Buy	259 +72	+39%	+$1.91K	﹤0.01%	829
2025 Q3	$5.3K	Buy	+187	New	+$5.07K	﹤0.01%	802
2025 Q1	–	Sell	-6	Closed	-$189	–	1720
2024 Q4	$189	Buy	+6	New	+$285	﹤0.01%	1063

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Aster Capital Management's ASTH Position: Q1 2026 in Review

Aster Capital Management sold out of Astrana Health (ASTH) in Q1 2026, closing a stake of 259 shares — an estimated $6.43K sold.

Aster Capital Management first reported a position in ASTH in Q4 2024 and held it in 3 quarters. The position peaked at $6.43K in Q4 2025. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

Aster Capital Management reported no remaining Astrana Health position as of Q1 2026 after selling out during the quarter.
Aster Capital Management sold 259 Astrana Health shares in Q1 2026, an estimated $6.43K.
Aster Capital Management first reported a position in Astrana Health in Q4 2024 and held it in 3 quarters.
Aster Capital Management's Astrana Health position peaked at $6.43K in Q4 2025.
171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.